T
Turn Therapeutics Inc.
TTRX · NASDAQ · Healthcare · 285M
Closing price
$12.00
+5.36% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
35.2×
Enterprise value / EBITDAEV/EBITDA
-50.9×
Free cash flow yieldFCF yield
-1.6%
Return on equityROE
-68.2%
Operating margin
—
Net debt / EBITDAbalance-sheet strength
1.6×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.